|
|
|
|
|
|
| Abstract Search | Browse Program and Abstracts | Schedule-at-a-Glance | Conference Mission & Sponsors | Program Committee | Contact Us |
| # | Title |
|---|---|
| 329 | AIDS Pathogenesis Elucidated by Divergent Host Responses during SIV Infection of Natural and Non-Natural Hosts
S. Staprans*, G. Silvestri, L. Perry, N. Kozyr, A. Fedanov, D. Garber, H. McClure, and M. Feinberg Emory Univ., Atlanta, GA, USA |
| 330 | Isolation of Epitopes Reactive with Antibody from HIV Viremia Controllers Using a Phage-Display Library
M. M. Berger*1, X.-Y. Jia1, M. M. Addo2, B. D. Walker2, R. D. Schrier3, J. G. Tilles1, and D. N. Forthal1 1Univ. of California, Irvine, USA; 2Massachusetts Gen. Hosp., Charlestown, USA; and 3Univ. of California, San Diego, USA |
| 331 | Increased Natural Killer Activity in HIV-1 Exposed but Noninfected Individuals among Vietnamese Intravascular Drug Users
D. Scott-Algara*1, P. Versmisse1, A. David1, L. T. Tram2, N. V. Ngai3, I. Theodorou3, T. X. Lien2, F. Barré-Sinoussi1, and G. Pancino1 1Inst. Pasteur, Paris, France; 2Inst. Pasteur, Hosp. Binh Trieu, Ho Chi Minh City, Vietnam; and 3Hosp. Pitié-Salpêtrière, Paris, France |
| 332 | Comparison of HIV-Specific Immunity in HIV Exposed Uninfected Individuals (EUs) Who Remain Seronegative with That in EUs Who Eventually Seroconvert
G. Makedonas*1, A. Merchant1, J. Bruneau2, F. Lamotthe2, R. Sekaly3, and N. Bernard1 1McGill Univ., Montreal, Canada; 2CHUM, Montreal, Canada; and 3Univ. de Montreal, Canada |
| 333 | Mucosal and Systemic HIV-Specific Immunity in HIV-Exposed but Uninfected Heterosexual Males
D. Trabattoni*1, S. Locaputo2, D. Luzzeri1, L. Lopalco3, F. Vichi2, C. Seletti1, F. Mazzotta2, and M. Clerici1 1Univ. of Milano, Italy; 2S.M. Annunziata Hosp., Firenze, Italy; and 3S. Raffaele Sci. Inst, Milano, Italy |
| 334 | Rapid Clearance of HIV in Primary HIV-1 Infection: Relationship to Symptoms and Progression to AIDS
W. Blattner*1, K. Oursler1, F. Cleghorn1, M. Charurat1, A. Sill1, C. Bartholomew2, N. Jack2, J. Edwards2, D. Goodman3, M. Maurice3, K. Weinhold3, and M. Greenberg3 1Inst. of Human Virology, Baltimore, MD, USA; 2MRFTT, Trinidad; and 3Duke Univ., Durham, NC, USA |
| 335 | The Sequence of Events Leading to Progression in Members of the Sydney Blood Bank Cohort
B. L. Herring1, W. Dyer2, N. Deacon3, M. Churchill3, N. K. Saksena1, J. Learmont2, M.-R. Birch, J. Zaunders4, and A. L. Cunningham*1 1WMI, Westmead, Australia; 2Sydney Red Cross Blood Bank, Australia; 3Macfarlane Burnet Ctr., Fairfield, Victoria, Australia; and 4St. Vincent's Hosp., Darlinghurst, Australia |
| 336 | Prolonged HAART and Therapeutic Vaccination with Canarypox vCP1452 and rgp160 Followed by Drug Cessation in Individuals Newly Infected with HIV-1
X. Jin*1, L. Zhang1, A. Hurley1, J. Binley1, V. Simon1, J. Murray2, S. Barsoum1, G. Deschenes1, J. Vanderhoeven1, C. Chung1, D. Schiller1, R. El Habib3, A. Perelson2, D. Ho1, and M. Markowitz1 1Aaron Diamond AIDS Res. Ctr., New York, NY, USA; 2Los Alamos Natl. Lab., New Mexico, USA; and 3Aventis Pasteur, Lyon, France |